Vaxxas has announced that the CEPI, has approved the progression of a $7.2 million program to develop heat-stable, ...

mRNA vaccines have emerged as a major scientific breakthrough in the development of ... Endosomal escape and removal through ...

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

They are composed of a lipid core stabilized ... particularly vaccines. 4 Biodegradable LNPs are also under investigation to reduce toxicity and improve compatibility with the body. A recent study in ...

How can we ensure that life-saving drugs or genetic therapies reach their intended target cells without causing harmful side ...

A Pseudonym for Protection As a healthcare professional, I write under a pseudonym, not because I want to remain anonymous, ...

3 In addition to mRNA vaccines, potent antibody responses can also be elicited by protein-based vaccines, such as the Novavax NVX-CoV2373 vaccine, that present the SARS-CoV-2 spike protein on the ...

PopVax awarded $2M for its patch-delivered mRNA influenza vaccine in collaboration with LTS Lohmann as part of BARDA’s Patch Forward Prize.